Concepedia

Publication | Closed Access

Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients

18

Citations

11

References

2023

Year

Abstract

Tofacitinib appears to be highly effective in targeting cutaneous manifestations in classic DM and ADM; however, minimal benefit in muscle strength in the DM or PM phenotype were observed.

References

YearCitations

Page 1